Ali Azizi

Family Medicine
11333 Sepulveda Blvd
Mission Hills, CA 91345

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses.

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses.

Journal: Vaccines
Published: April 26, 2026

Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodies.

Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodies.

Journal: Frontiers in immunology
Published: January 08, 2026

Future directions in combating outbreaks at CEPI Centralized Laboratory Network.

Future directions in combating outbreaks at CEPI Centralized Laboratory Network.

Journal: Human vaccines & immunotherapeutics
Published: September 18, 2025

Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines.

Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines.

Journal: Vaccines
Published: June 02, 2025

Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine Formulations.

Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine Formulations.

Journal: Vaccines
Published: April 29, 2025

Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network.

Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network.

Journal: Frontiers in immunology
Published: January 31, 2025

Preparedness and priority research to tackle the mpox outbreak response.

Preparedness and priority research to tackle the mpox outbreak response.

Journal: Nature medicine
Published: January 03, 2025

Driving consistency: CEPI-Centralized Laboratory Network's conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines.

Driving consistency: CEPI-Centralized Laboratory Network's conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines.

Journal: Human vaccines & immunotherapeutics
Published: May 06, 2024

Unifying global efforts by CEPI's centralized laboratory network.

Unifying global efforts by CEPI's centralized laboratory network.

Journal: Frontiers in immunology
Published: March 20, 2024

Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network.

Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network.

Journal: NPJ vaccines
Published: February 09, 2024

The CEPI centralized laboratory network for COVID-19 will help prepare for future outbreaks.

The CEPI centralized laboratory network for COVID-19 will help prepare for future outbreaks.

Journal: Nature medicine
Published: September 19, 2023

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.

Journal: The Lancet. Microbe
Published: July 28, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026